UK Markets close in 3 hrs 44 mins
  • FTSE 100

    6,330.94
    -31.99 (-0.50%)
     
  • FTSE 250

    19,212.45
    -183.89 (-0.95%)
     
  • AIM

    1,038.41
    +0.38 (+0.04%)
     
  • GBP/EUR

    1.1180
    -0.0031 (-0.28%)
     
  • GBP/USD

    1.3334
    -0.0022 (-0.1667%)
     
  • BTC-GBP

    12,785.23
    -69.82 (-0.54%)
     
  • CMC Crypto 200

    333.51
    -37.01 (-9.99%)
     
  • S&P 500

    3,629.65
    -5.76 (-0.16%)
     
  • DOW

    29,872.47
    -173.77 (-0.58%)
     
  • CRUDE OIL

    45.39
    -0.32 (-0.70%)
     
  • GOLD FUTURES

    1,809.40
    -1.80 (-0.10%)
     
  • NIKKEI 225

    26,644.71
    +107.40 (+0.40%)
     
  • HANG SENG

    26,894.68
    +75.23 (+0.28%)
     
  • DAX

    13,316.43
    +29.86 (+0.22%)
     
  • CAC 40

    5,593.96
    +27.17 (+0.49%)
     

M1 Kliniken AG: Number of treatments increase by almost 20 % in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities.

·3-min read

DGAP-News: M1 Kliniken AG / Key word(s): 9 Month figures/Expansion
04.11.2020 / 08:00
The issuer is solely responsible for the content of this announcement.


M1 Kliniken AG: Number of treatments increase by almost 20% in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities.

Berlin, 4.11.2020 - In contrast to the worsening pandemic situation, M1 Kliniken AG continues to record strong demand. The number of injection treatments and surgical treatments performed in the German market in the 3rd quarter of 2020 rose by almost 20% year-on-year to over 65,000. The international locations are also expanding their market position and were able to significantly increase the number of treatments. In the 3rd quarter of 2020, a further practice was opened in Austria (Graz).

M1 Kliniken AG expects the positive development to continue in the 4th quarter 2020. To date, the company is not affected by the current lock-down arrangements and treatments will continue on the basis of a comprehensive hygiene concept. The Australian centers resumed operations at the end of October after a lock-down of more than three months. The high expectations for the restart were more than exceeded. In addition, the first practice in Eastern Europe (Zagreb/Croatia) was opened at the end of October 2020.

For the further expansion of the practice network, M1 Kliniken AG is closely monitoring the local pandemic developments. For the time being, no further international projects will be started and a sustained decline in the number of corona cases will be awaited. In the German market, four new locations are currently being developed in cities without M1 presence. M1 is also recruiting new doctors to further expand treatment capacities.

In addition, M1 has been involved in COVID19 testing since mid-year. Between July and October 2020, more than 25,000 test samples have been taken for corporate customers. A first COVID test centre in Berlin for "walk-in testing" as a prototype for further locations in Germany was opened in early November 2020.

About M1 Kliniken AG
M1 Kliniken AG is the leading provider of beauty medicine health services in Germany. In the aesthetic and surgical field, the group offers products and services of the highest quality. Under the brands M1 Med Beauty, beauty medical treatments are currently offered at more than 35 locations. The 'M1 Schlossklinik' for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been pushing ahead with its international expansion and is currently active in Austria, the Netherlands and Australia. The Group is now also growing in other European countries and markets high-quality products to private customers, doctors, pharmacies and wholesalers under the M1 Select and M1 Aesthetics brands.




Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M: ir@m1-kliniken.de


04.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

M1 Kliniken AG

Grünauer Straße 5

12557 Berlin

Germany

Phone:

+49 (0)30 347 47 44 14

Fax:

+49 (0)30 347 47 44 17

E-mail:

ir@m1-kliniken.de

Internet:

https://www.m1-kliniken.de

ISIN:

DE000A0STSQ8

WKN:

A0STSQ

Listed:

Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange

EQS News ID:

1145081


 

End of News

DGAP News Service

show this
show this